Lushang Freda Pharmaceutical Co., Ltd. Class ASSE: 600223

"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Sep 12, 2026 · Issued by Lushang Freda Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Lushang Freda Pharmaceutical Co., Ltd. Class A

"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through AgreementSep 2
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Notice on Convening the 2nd Extraordinary General Meeting in 2026Aug 26
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Signing of the Financial Services Agreement with Shandong Commercial Group Finance Co., Ltd. and Related Party TransactionsAug 15
"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Progress in Transfer of Certain Company Shares under Agreement by Controlling Shareholder and Changes in Equity InterestsAug 12

All Lushang Freda Pharmaceutical Co., Ltd. Class A news releases